Providence Ventures

Providence Ventures generally targets mid-to late-stage venture investments across Healthcare IT, MedTech, and tech-enabled services. Over the life of an investment, they seek to deploy $8 to $15 million. Their best opportunities to add value are investments that align the interests of their portfolio companies and the innovation priorities of Providence Health & Services, through broad solution deployment and strategic insight. The innovation opportunities PHS targets as a large health system tend to reflect the priorities of the US health system overall. They welcome the opportunity to partner with established venture funds as co-investors, however, syndication is not a prerequisite for their participation. Providence Ventures is founded in 2014 which manages $300 million in venture capital funds on behalf of Providence St. Joseph Health (PSJH), one of the largest integrated health systems in the US. The company's​ mission is to achieve venture and growth equity class returns through direct investments in innovative healthcare companies that improve health outcomes, lower costs, and enhance the experience of our patients and caregivers. It offers investment capital, combined with health system expertise, to companies addressing existing and emerging pain points in healthcare. Providence Ventures partners with our portfolio companies to refine existing solutions, while expanding their adoption within and beyond our health system.

Christiana DelloRusso Ph.D

Partner

Branden Fini

Principal

Galles, Daniel J.

Partner

Jeff Stolte

Senior Partner

28 past transactions

impact.com

Private Equity Round in 2022
impact.com the leading global partnership management platform, has been transforming the way enterprises discover and manage all types of partnerships — including affiliates, influencers, commerce content publishers, B2B, and more — since its founding in 2008. Their powerful, purpose-built platform helps businesses — brands, publishers, and agencies — to build authentic, enduring, and rewarding relationships with both publishers and consumers. By providing visibility across the entire consumer journey, they are able to aggregate, orchestrate, and optimize the total value of the entire mix of partnerships with ease and transparency — driving growth and creating new value for consumers. To learn more about how impact.com's technology platform and partnerships marketplace is driving revenue growth for global enterprise brands such as Walmart, Uber, Shopify, Lenovo, L'Oreal, Fanatics, Levi's and 1-800-Flowers, visit www.impact.com.

Wildflower Health

Venture Round in 2022
Wildflower Health focuses on its client's needs and integrates services into existing sustainability programs. Its team is passionate about harnessing user-centered design and technology to deliver products that drive smarter healthcare decisions. It was founded in 2012 and headquartered in San Francisco, California.

DexCare

Series B in 2022
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Xealth

Series B in 2021
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

Kno2

Series A in 2021
Kno2 develops a cloud-based health information platform designed to send and receive patient information electronically. Its cloud-based health information platform organizes, manages, shares, and captures unstructured patient information from the common sources such as paper-based documents, faxes, and digital images convert them in the right format, and make those available in patients portals of healthcare providers, enabling them to take critical medical decisions without delay.

Arrive Health

Funding Round in 2021
Arrive Health provides access to affordable, quality care by delivering accurate, patient-specific cost and coverage data to providers, care teams, and patients. The company was founded in 2013 and is headquartered in Denver, Colorado, United States.

Protenus

Series D in 2021
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

TailorMed

Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

DexCare

Series A in 2021
DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Livara Health

Series A in 2021
Livara Health is a provider of non-operative, personalized treatment for musculoskeletal conditions.

Lyra Health

Series D in 2020
Lyra helps companies improve access to effective, high-quality mental health care for their employees. Lyra's matching technology and innovative digital platform connect members to a curated network of top therapists and coaches, which results in 3x more people receiving care and 7x better outcomes than traditional plans and EAPs. Members can find the right personalized care, match with the right provider for their needs, and feel motivated and supported throughout the entire treatment journey.

Lyra Health

Series C in 2020
Lyra helps companies improve access to effective, high-quality mental health care for their employees. Lyra's matching technology and innovative digital platform connect members to a curated network of top therapists and coaches, which results in 3x more people receiving care and 7x better outcomes than traditional plans and EAPs. Members can find the right personalized care, match with the right provider for their needs, and feel motivated and supported throughout the entire treatment journey.

Twistle

Venture Round in 2020
Twistle is a health care platform that helps healthcare providers connect with patients, keeping them on track for faster recovery. Its "Care Plan Automation"​ platform helps clinical teams streamline care pathways by automating follow-up and surveillance. Its mobile health tool connects providers and patients through secure automated messaging, photo/lab sharing, surveys, smart device/EHR integration, and more. The company was founded in 2011 and is headquartered in Seattle, Washington.

Kyruus

Series D in 2020
Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions—for consumers, access centers, and referral networks—enables a consistent patient experience across multiple points of access, while aligning provider supply with patient demand. The company’s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications. Kyruus was founded in 2010 and is headquartered in Boston, Massachusetts.

Protenus

Series C in 2019
Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes’ America’s Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

Omada Health

Series D in 2019
Omada Health is a digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives. The program is personalized to meet each participant’s unique needs as they evolve, ranging from diabetes prevention, type 2 diabetes management, hypertension, behavioral health, and musculoskeletal issues. Omada combines professional health coaching, connected health devices, real-time data, and personalized feedback to deliver clinically meaningful results. The company is the largest CDC-recognized provider of the National Diabetes Prevention Program.

Xealth

Series A in 2019
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

Bolder Surgical

Series C in 2019
Bolder Surgical exists to serve healthcare providers by developing precisely designed surgical instruments that allow access to confined and often delicate structures. By addressing this comparatively small market, they are able to meet the specific needs of surgeons and promote the advancement of surgical approaches that reach beyond what traditional instruments have allowed. The company was founded in 2010 and is headquartered in Boulder, Colorado.

Lyra Health

Series B in 2018
Lyra helps companies improve access to effective, high-quality mental health care for their employees. Lyra's matching technology and innovative digital platform connect members to a curated network of top therapists and coaches, which results in 3x more people receiving care and 7x better outcomes than traditional plans and EAPs. Members can find the right personalized care, match with the right provider for their needs, and feel motivated and supported throughout the entire treatment journey.

Kyruus

Corporate Round in 2018
Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions—for consumers, access centers, and referral networks—enables a consistent patient experience across multiple points of access, while aligning provider supply with patient demand. The company’s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications. Kyruus was founded in 2010 and is headquartered in Boston, Massachusetts.
Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care. With a nationwide network engaged with every national health plan in the country, hundreds of hospitals and health systems and tens of thousands of providers, Collective’s system-agnostic platform is trusted by care teams to identify at-risk and complex patients and facilitate actionable collaboration to make better care decisions and improve outcomes. Based in Salt Lake City, Collective is proven to streamline transitions of care, improve coordination across diverse care teams, and reduce medically unnecessary hospital admissions.
IRIS preventative screening for Diabetic Retinopathy is as simple and quick as taking a patient's blood pressure or stepping on a scale, and can be just as helpful to physicians in helping to detect eye disease or other disorders. The retina is a window into the body. Minute changes in the blood vessels of the retina can be early indicators of issues elsewhere.

Bona Film Group

Private Equity Round in 2016
Bona Film Group Limited is a film distributor in China, with an integrated business model encompassing film distribution, production, exhibition and talent representation. Bona distributes films to Greater China, Korea, Southeast Asia, the United States and Europe, invests in and produces movies in a variety of genres, owns and operates twenty movie theaters and manages a range of talented and popular Chinese artists.

N-of-One

Series B in 2016
N-of-One Therapeutics provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and other diagnostic and treatment opportunities for various cancer types.

Gauss Surgical

Series B in 2016
Gauss Surgical is a med-tech company that develops a vision-based platform for accurate and real-time measurement of surgical blood loss. They develop beautiful applications for iOS backed by sophisticated algorithms and a robust, HIPAA-compliant technical stack to enable real-time monitoring during surgery. The company was incorporated in 2011 and is headquartered in Menlo Park, California.

Sqord

Seed Round in 2016
Sqord is a social health company that leverages a unique gamification platform coupled with a low-cost wearable device to get kids physically active again to address the shocking decline in healthy habits in kids due to increasingly sedentary, unhealthy lifestyles.

InDemand Interpreting

Venture Round in 2015
InDemand Interpreting is a medical interpretative service company,working to bridge the language gap for patients. Our company is built around nationally certified medical interpreters who support healthcare encounters via video remote, in person or over the phone. Started in 2007, our company pioneered the use of video remote technology for interpreting in healthcare.

Sqord

Venture Round in 2015
Sqord is a social health company that leverages a unique gamification platform coupled with a low-cost wearable device to get kids physically active again to address the shocking decline in healthy habits in kids due to increasingly sedentary, unhealthy lifestyles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.